![Norbert W. Bischofberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Norbert W. Bischofberger
Director/Board Member at
VIR BIOTECHNOLOGY, INC.
Net worth: 357 760 $ as of 30/09/2026
Profile
Norbert W.
Bischofberger is the founder of Rezo Therapeutics, Inc., founded in 2022, where the title held is Director.
Current jobs include Director at Morphic Therapeutic, Inc. since 2019, Independent Director at Vir Biotechnology, Inc. starting in 2024, Director at MiNA Therapeutics Ltd. starting in 2025, and Scientific Advisor at VV Manager LLC.
Former jobs include Director at Kronos Bio, Inc. from 2018 to 2025, Director at InCarda Therapeutics, Inc., Independent Director at Morphic Holding, Inc. from 2019 to 2024, Chief Scientific Officer & Executive VP- Research at Gilead Sciences, Inc. from 2007 to 2018, Manager-DNA Synthesis Group at Genentech, Inc. from 1986 to 1990, and Independent Member-Supervisory Board at Bayer AG from 2017 to 2024.
Education includes a doctorate from the Swiss Federal Institute of Technology in 1983 and an undergraduate degree from the University of Innsbruck in 1980.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/05/2026 | 32,000 ( 0.02% ) | 357 760 $ | 30/09/2026 |
Norbert W. Bischofberger active positions
| Companies | Position | Start |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Director/Board Member | 29/05/2024 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Director/Board Member | 14/06/2019 |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Founder | 17/11/2022 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Consultant / Advisor | - |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology Develops biological and medical products | Director/Board Member | 01/03/2025 |
Former positions of Norbert W. Bischofberger
| Companies | Position | End |
|---|---|---|
| KRONOS BIO, INC. | Chief Executive Officer | 03/12/2024 |
| MORC HOLD | Director/Board Member | 16/08/2024 |
| BAYER AG | Director/Board Member | 26/04/2024 |
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 30/04/2018 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Education of Norbert W. Bischofberger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
University of Innsbruck
 University of Innsbruck Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that develops and manufactures innovative therapies for atrial fibrillation & cardiac rhythm disorders | Commercial Services |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology Develops biological and medical products | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
VV Manager LLC
VV Manager LLC Investment ManagersFinance Vida Ventures invests in companies located in the United States. The firm targets companies operating in the life science, healthcare, medicine, and biotechnology sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
- Stock Market
- Insiders
- Norbert W. Bischofberger
